Why the study?
Does weekly remote monitoring-driven management reduce the composite of all-cause death or unplanned cardiovascular hospitalization in heart failure patients with cardiac implanted electronic devices compared to usual care?
Does weekly remote monitoring-driven management reduce the composite of all-cause death or unplanned cardiovascular hospitalization in heart failure patients with cardiac implanted electronic devices compared to usual care?
The REM-HF study is a multicentre randomized trial designed to evaluate the clinical and cost-effectiveness of weekly remote monitoring-driven management compared to usual care in heart failure patients with implanted cardiac devices.
No takes yet. Share an insight, caveat, or question.
Remote monitoring does not reduce death or CV hospitalization versus usual care; challenges routine adoption and leaves open need for refined algorithms.
Morgan et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: